Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

The group now has 400 approvals and has filed over 465 abbreviated new drug applications (ANDAs) since the commencement of ...

"CSIR-CDRI's deep-rooted expertise in biomedical research, coupled with Zydus' innovative approach to drug discovery and ...

Environmentally, Perfect Day’s precision fermentation technology means it will be less reliant on conventional animal farming ...

India - Conduct Of Defendants In A Quia Timet Action. Legal News and Analysis - India - Intellectual Property - Conventus Law ...

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a muted opening on Wednesday. (Photo: Freepik) GIFT Nifty indicated that Indian equity indices BSE Sensex and ...

Zydus Lifesciences shares faced selling pressure during the September 17 trading session following the board’s approval to acquire the API business of Sterling Biotech for ₹84 crore.

In August this year when Zydus acquired a 50 per cent stake in Sterling Biotech Ltd (SBL), the company negotiated for the right to acquire the 'Target Business' of SBL at a pre-defined value. "This ...

Zydus Lifesciences shares faced under selling pressure on September 17 trading session after the board approval for acquisition of API business of Sterling Biotech for Rs 84 crore. The ...